Navigation Links
HIV Prevention Pill Cost-Effective for High-Risk Men: Study
Date:4/17/2012

TUESDAY, April 17 (HealthDay News) -- A once-a-day pill to prevent HIV infection could significantly reduce the spread of the AIDS-causing virus, but would only be cost-effective if limited to men at very high risk for HIV infection, according to a new study.

Stanford University researchers created an economic model to analyze the use of the combination drug tenofovir-emtricitabine (brand name Truvada). A clinical trial found that the drug reduced a person's risk of HIV infection by an average of 44 percent when taken daily. In some people, the drug reduced the risk by 73 percent.

But the drug is expensive -- $26 a day, or $10,000 a year.

The economic model focused on men who have sex with men, a group that accounts for more than of the 56,000 new HIV infections a year in the United States, according to the U.S. Centers for Disease Control and Prevention.

The researchers found that giving the pill to all U.S. men who have sex with men would cost $495 billion over 20 years, compared to $85 billion if the pill was given only to gay men at particularly high risk for HIV infection -- those who have five or more sexual partners in a year.

Without the use of the anti-HIV pill, there would be more than 490,000 new HIV infections among gay men in the United States over the next 20 years. If 20 percent of men who have sex with men took the pill daily, there would be nearly 63,000 fewer infections over the next 20 years. If 20 percent of high-risk gay men took the pill, there would be 41,000 fewer infections over 20 years, the researchers said.

The study is in the April 17 issue of Annals of Internal Medicine.

Giving the pill to high-risk gay men represents good value, according to study first author Jessie Juusola, a Ph.D. candidate in management science and engineering in the School of Engineering at Stanford University.

"However, even though it provides good value, it is still very expensive," she said in a university news release. "In the current health-care climate, (these) costs may become prohibitive, especially given the other competing priorities for HIV resources, such as providing treatment for infected individuals."

Cost could be significantly reduced if the pill is found to be effective when used intermittently rather than daily. Clinical trials are under way to assess the drug's effectiveness when it is used less often than once a day.

More information

The U.S. Centers for Disease Control and Prevention has more about HIV transmission.

-- Robert Preidt

SOURCE: Stanford University, news release, April 16, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Decision guide reduced uncertainty over breast cancer prevention, study finds
2. Report says new evidence could tip the balance in aspirin cancer prevention care
3. $4.2 million grant helps plan, launch first Alzheimers prevention trials
4. How cost effective are US cancer prevention services?
5. As Youth Baseball Season Nears, Experts Urge Injury Prevention
6. Stents and surgery for blocked neck arteries are neck-and-neck as lasting stroke prevention
7. March of Dimes launches Prematurity Prevention Network
8. Many strategies to increase physical activity for kids lack injury prevention measures
9. Revamping HIV-prevention programs in the Caribbean
10. Experts Urge Public Action to Aid Cancer Prevention
11. U.S. Diabetes Prevention Program Might Avert 885,000 Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Northern Kentucky - Cincinnati, Ohio (PRWEB) , ... ... ... leader in the production of miniature, folded, pharmaceutical inserts and outserts. As ... & Serialization Device. This addition will enable Flottman to individually code professional ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... celebrated its 10th anniversary with the grand opening of the Sober College Robert ... event spanned two days, December 2-3, and was attended by an overwhelming amount ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/9/2016)... ... 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... summer of 2016. The program was made possible by a Pennsylvania Department of ... Health and Human Services Administration. The broadcast, Use Your Head: Properly Managing ...
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of ... report to their offering. ... The report also analyses the market by the following Technology Types: Label-Free ... the US, Canada , Japan , ... Latin America , and Rest of World. Annual ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, Inc. ... (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to ... for the treatment of bacterial infections including those ... recognized as an attractive antibacterial target for more ... of suitable chemical starting points has hampered its ...
Breaking Medicine Technology: